01 Shift Towards Latex-Free Tourniquets Use of latex-free tourniquets gains momentum in hospital settings. BD has transitioned its entire tourniquet portfolio to exclusively latex-free materials, aligning with the hospital's broader move to eliminate latex products across its facilities. This transition addresses compliance requirements and also accelerates the adoption of latex free disposables, creating a favourable growth pathway for manufacturers.
02 Regulatory Push Towards Single-Use Medical Devices in Europe A major trend in the disposable tourniquets market is the growing preference for disposable tourniquets, driven by stringent regulatory frameworks governing single use devices in Europe. Europe’s MDR 2017/745 tightened rules on single-use devices, with most countries banning or restricting reprocessing. France prohibits it entirely, and the UK’s strict liability framework makes re-manufacturing impractical. Even in Germany, where regulated reprocessing is allowed, compliance costs are pushing hospitals toward disposables, driving higher adoption of disposable tourniquets across key markets.This trend reflects increasing demand for single-use disposable tourniquets.
01 Rising Blood Donation Public blood donation drives are expanding in countries like Brazil and Mexico, creating more demand for disposable tourniquets, as it is mandatory to use tourniquets during blood withdrawal. For example, in June 2025, the Pan American Health Organization (PAHO) reported that 23 Latin American and Caribbean nations collected over 9.2 million units of blood in 2023, a 15.5% jump from 2020.This surge in blood donations leads to increased demand for disposable tourniquets in hospitals and clinics, which, in turn, supports the market growth.
01 Procurement Focuses on Low-Cost Unit Price Various public buyers issue tenders that prioritize the lowest cost per unit disposable tourniquets. This impacts the margins of manufacturers that offer branded tourniquets, leading to a reduction in the profit margin, which, in turn, impacts the overall market growth.
01 New Initiatives to Strengthen the Distribution Network The presence of approved medical suppliers in the U.S. and UK markets ensures that disposable tourniquets are readily available, efficiently delivered, and consistently stocked, even in rural healthcare facilities. In the U.K., the NHS Supply Chain provides various advantages to manufacturers, including reduced pricing pressures, minimized tendering time, and back office cost savings. The NHS alone uses approximately 330,000 disposable tourniquets annually within its trusts due to the strong distribution networks of below companies:Thus, a broad distribution network presents opportunities for manufacturers to accelerate market penetration and reduce the need for building private supply chains.
May 2026 Mölnlycke Health Care expanded its single-use vascular access portfolio with new sterile procedure solutions designed to enhance infection prevention and improve patient safety during blood collection and intravenous access procedures.
February 2026 Vygon Group expanded the availability of its single-use tourniquet portfolio across additional European markets, strengthening its infection prevention offering for hospitals, outpatient clinics, and diagnostic laboratories.
November 2025 Sarstedt AG & Co. KG introduced an enhanced range of single-use latex-free disposable tourniquets, designed to improve patient safety and reduce the risk of cross-contamination during venipuncture and blood collection procedures.
September 2025 Medline Industries expanded its medical consumables portfolio with additional single-use disposable tourniquets, supporting infection control initiatives in hospitals, ambulatory surgical centers, and emergency care settings.